Hyperuricemia starts at 360 micromoles (6mg/dL)

Joint Bone Spine

Volumn 82, Issue 3, 2015, Pages 141-143

  Bardin, Thomas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cardiovascular risk; Gout; Hyperuricemia; Threshold; Uricemia

Indexed keywords

CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CRYSTALLIZATION; EDITORIAL; GOUT; HUMAN; HYPERURICEMIA; PHYSICAL CHEMISTRY; POPULATION; RISK ASSESSMENT; URIC ACID BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; RISK FACTOR;

URIC ACID;

CARDIOVASCULAR DISEASES; GOUT; HUMANS; HYPERURICEMIA; RISK FACTORS; URIC ACID;

EID: 84929261734     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2015.01.002     Document Type: Editorial

References (37)

1. Richette P., Perez-Ruiz F., Doherty M., et al. Improving cardiovascular and renal outcomes in gout: what should we target?. Nat Rev Rheumatol 2014, 10:654-661. 10.1038/nrrheum.2014.124.
2. Bardin T., Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol 2014, 26:186-191.
3. Ryckewaert A. Rhumatologie. Pathologie osseuse et articulaire 1987, Flammarion Médecine Sciences, Paris.
4. Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63:3136-3141.
5. Trifiro G., Morabito P., Cavagna L., et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study. Ann Rheum Dis 2013, 7:694-700.
6. O'Sullivan J.B., Francis J.O., Kantor N. Comparison of a colorimetric (automated) with an enzymatic (manual) uric acid procedure. Clin Chem 1965, 11:427-435.
7. Ryckewaert A., Dry J., Paolaggi F. Hyperuriémie. I Remarque sur les methodes de mesure de l'uricémie dans le sang; definition de l'uricémie normale. Rev Rhum Mal Osteoartic 1965, 32:447-451.
8. Goldstein R.A., Becker K.L., Moore C.F. Serum urate in healthy men. Intermittent elevations and seasonal effect. N Engl J Med 1972, 287:649-650.
9. Yu K.H., Luo S.F., Tsai W.P., et al. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion. Rheumatology (Oxford) 2004, 43:1541-1545.
10. Akizuki S. Serum uric acid levels among thirty-four thousand people in Japan. Ann Rheum Dis 1982, 41:272-274.
11. Hall A.P., Barry P.E., Dawber T.R., et al. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 1967, 42:27-37.
12. Mikkelsen W.M., Dodge H.J., Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan 1959-1960. Am J Med 1965, 39:242-251.
13. Sturge R.A., Scott J.T., Kennedy A.C., et al. Serum uric acid in England and Scotland. Ann Rheum Dis 1977, 36:420-427.
14. Wigley R.D., Prior I.A., Salmond C., et al. Rheumatic complaints in Tokelau, II. A comparison of migrants in New Zealand and non-migrants. The Tokelau Island migrant study. Rheumatol Int 1987, 7:61-65.
15. Hochberg M.C., Thomas J., Thomas D.J., et al. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum 1995, 38:628-632.
16. Hak A.E., Curhan G., Grodstein F.D., et al. Menopauses, postmenopausal hormone use, and serum uric acid in US women: the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008, 10:R116.
17. Glynn R.J., Campion E.W., Silbert J.E. Trends in serum uric acid levels 1961-1980. Arthritis Rheum 1983, 26:87-93.
18. Loeb J.N. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum 1972, 15:189-192.
19. Hollander J.L., Stoner E.K., Brown E.M., et al. Joint temperature measurement in the evaluation of anti-arthritic agents. J Clin Invest 1951, 30:701-706.
20. McGill N.W., Dieppe P.A. Evidence for a promoter of urate crystal formation in gouty synovial fluid. Ann Rheum Dis 1991, 50:558-561.
21. Katz W. Role of proteoglycans in the development of gouty arthritis. Uric acid 1978, 347-364. Springer-Verlag, Berlin. W. uric acid, Kelley, I.M. Weiner (Eds.).
22. Roddy E., Zhang W., Doherty M. Gout and nodal osteoarthritis: a case-control study. Rheumatology (Oxford) 2008, 47:732-733.
23. Pascual E., Martinez A., Ordonez S. Gout: the mechanism of urate crystal nucleation and growth. A hypothesis based in facts. Joint Bone Spine 2013, 80:1-4.
24. Logan J.A., Morrison E., McGill P.E. Serum uric acid in acute gout. Ann Rheum Dis 1997, 56:696-697.
25. Schlesinger N., Baker D.G., Schumacher H.R. Serum urate during bouts of acute gouty arthritis. J Rheumatol 1997, 24:2265-2266.
26. Brauer G.W., Prior I.A. A prospective study of gout in New Zealand Maoris. Ann Rheum Dis 1978, 37:466-472.
27. Campion E.W., Glynn R.J., DeLabry L.O. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421-426.
28. Lin K.C., Lin H.Y., Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 2000, 27:1045-1050.
29. Chen J.H., Yeh W.T., Chuang S.Y., et al. Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol 2012, 31:239-245.
30. Bhole V., de Vera M., Rahman M.M., et al. Epidemiology of gout in women. Fifty-two-year follow-up of a prospective cohort. Arthritis Rheum 2010, 62:1069-1076.
31. Duskin-Bitan H., Cohen E., Goldberg E., et al. The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort. Clin Rheumatol 2014, 33:549-553.
32. Chowalloor P.V., Keen H.I. A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia. Ann Rheum Dis 2013, 72:638-645.
33. Grahame R.J.T. Scott, clinical survey of 354 patients with gout. Ann Rheum Dis 1970, 29:461-468.
34. Ryckewaert A., Dry J., Paolaggi F., et al. [Blood uric acid levels in gout patients]. Rein Foie 1966, 8:109-113.
35. Zhang W., et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006, 65:1312-1324.
36. Grayson P.C., Kim S.Y., LaValley M., et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011, 63:102-110.
37. Gaffo A.L., Jacobs D.R., Sijtsma F., et al. Serum urate association with hypertension in young adults: analysis from the coronary artery risk development in young adults cohort. Ann Rheum Dis 2013, 72:1321-1327.